XORTX Therapeutics Inc. submitted a Form 6-K to report on matters relevant for September 2024, specifically signed on September 3, 2024, indicating compliance with SEC regulations. This is a neutral event and is not significant for investors.
AI Assistant
XORTX THERAPEUTICS INC
2024
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.